Background: High triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) levels are traditional risk factors for type 2 diabetes mellitus (T2DM). This study evaluated the dose-response relationship between the TG/HDL-C ratio and T2DM risk. Methods: The study included 11 946 adults without baseline diabetes from the Rural Chinese Cohort Study. Cox proportional hazards regression was used to investigate the association between the TG/HDL-C ratio and T2DM. The dose-response relationship was evaluated by restricted cubic spline analysis. In addition, pooled odds ratios (OR) were calculated with a random-effects model in a meta-analysis including the present study and another three eligible articles. Results: During 2007-14, 618 patients with T2DM were identified (9.68/1000 person-years). People in the highest TG/HDL-C ratio quartile had a higher T2DM risk than those in the lowest quartile (adjusted hazard ratio [aHR] 2.11, 95% confidence interval [CI] 1.55-2.86); however, the association between the TG/HDL-C ratio and T2DM was stronger in females than males (aHR 1.27 [95% CI 1.16-1.39; and 1.19 [95% CI 1.04-1.37], respectively). In body mass index-specific analysis, the association was stronger in normal weight than overweight/obese people. The dose-response meta-analysis showed that a 1-unit increment in the TG/HDL-C ratio increased the T2DM risk by 28% (95% CI 20%-36%), with a positive linear relationship (P linear = 0.326). Conclusions: The TG/HDL-C ratio was an independent risk factor of T2DM, especially in females, and linearly increased the risk of T2DM; thus, it may be a useful indicator to identify future T2DM.
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Introduction
Type 2 diabetes mellitus (T2DM) has become one of the world's leading disease burdens, especially in China. 1, 2 The prevalence of T2DM in Chinese people has continued to increase, from 0.9% in 1980 to 11.6% in 2010. 3 The International Diabetes Federation estimated that, in China, 114.4 million adults aged 18-79 years had diabetes in 2017. 4 Thus, exploring and intervening in the risk factors for T2DM are important. 5 Dyslipidemia is a common feature of T2DM. 6, 7 High triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) levels are traditional risk factors for insulin resistance (IR) and T2DM. [8] [9] [10] [11] Some studies have suggested that the TG/HDL ratio is closely related to IR, 11, 12 but data on the association between the TG/HDL-C ratio and T2DM are limited, especially in Chinese people. So far, only one cohort study of 687 individuals in China explored the association, finding that the TG/HDL-C ratio independently increased the risk of T2DM in a general population. 13 In addition, although several studies in other countries have shown that a high TG/HDL-C ratio increases the risk of T2DM, [14] [15] [16] the specific dose-response relationship between the lipid ratio and T2DM has not been reported.
In this context, the aims of the present study were to investigate whether the TG/HDL-C ratio is associated with T2DM incidence, and to assess the dose-response relationship between the TG/HDL-C ratio and the incidence of T2DM. In addition, we validated our conclusion with a meta-analysis of our findings and those of previously published prospective studies.
Methods

Study population
The data used in the present study are from the Rural Chinese Cohort Study, details of which, specifically design and implementation, have been described previously. 17, 18 Briefly, the prospective cohort study included 20 194 adults at baseline during July-August 2007 and July-August 2008 by random cluster sampling; 17 265 participants were followed-up in July-August 2013 and July-October 2014. The follow-up rate was 85.5%. The present study excluded urban residents (n = 155) or individuals with missing data for TG levels (n = 34) or HDL-C levels (n = 18), those using lipid-lowering medications (n = 2158), or those with diabetes (n = 1721) at baseline. In addition, 1110 people died and 2519 individuals had missing data for T2DM during the followup. Furthermore, to reduce the effect of extreme values of the TG/HDL-C ratio, individuals with a TG/HDL-C ratio < 0.32 (1st percentile) or > 6.41 (99th percentile) were excluded. 19 The study protocol was approved by the Zhengzhou University Medical Ethics Committee in accordance with principles of the 1975 Declaration of Helsinki and its later amendments; all participants provided signed informed consent.
Measurement and data collection at baseline
A standard questionnaire was used to obtain data on demographics (age, sex, and education level), life style (smoking, alcohol use, and physical activity), family history of disease, and personal history of disease. A smoker was defined as someone who smoked more than 100 cigarettes in their lifetime. 20 Alcohol use was defined as drinking alcohol more than 12 times during the past year. 18 Physical activity level was assessed using the International Physical Activity Questionnaire (IPAQ) scoring protocol. 21 All participants were asked to wear light clothing and no shoes for physical measurements. Height, weight and waist circumstance (WC) were measured using standard protocols and recorded as the average of two measurements. Body mass index (BMI; kg/m 2 ) was calculated as weight divided by height squared. Normal weight, overweight, and obesity were defined as BMI <24, 24-27.9, and ≥ 28 kg/m 2 , respectively, according to the Working Group on Obesity in China definitions. 22 After participants had rested for at least 5 min while seated, blood pressure was measured three times using an electronic sphygmomanometer (HEM770AFuzzy; Omron, Kyoto, Japan) on the unclothed right upper arm, at intervals of 30 s, with the average of three measurements recorded. Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg and/or the current use of antihypertensive medication and/or a self-reported physician diagnosis of hypertension.
Blood samples were drawn from the antecubital vein after overnight fasting and collected into vacuum tubes. Fasting plasma glucose (FPG), total cholesterol (TC), TG, and HDL-C levels were measured. The Friedewald formula was used to calculate serum concentrations of low-density lipoprotein cholesterol (LDL-C). 23 The TG/HDL-C ratio was calculated as TG (mmol/L) divided by HDL-C (mmol/L) and was classified into quartiles.
The same standards were enforced at baseline and follow-up. Type 2 diabetes mellitus was defined as FPG ≥7.0 mmol/L and/or the use of insulin or oral hypoglycemic medication and/or a self-reported history of T2DM, and excluded type 1 diabetes mellitus (T1DM). 24 
Meta-analysis
Literature searches were performed using the Medline (via PubMed), Embase, and China National Knowledge Internet (CNKI) databases on 17 November 2017 for reports of eligible studies. The computer-based search combined MeSH terms and free text related to the exposure (e.g. TG/HDL, triglycerides to highdensity lipoprotein) and outcome (e.g. type 2 diabetes, non-insulin-dependent diabetes mellitus). Eligible studies had to: (i) be based on a prospective study of adults (prospective cohort study or prospective nested casecontrol study); (ii) include a categorical TG/HDL-C ratio and range; (iii) report relative risks, odds ratios (ORs) or hazard ratios (HRs) with 95% confidence intervals (CIs), or data that could be used for the calculation of these parameters; and (iv) include the number of cases and controls in each TG/HDL-C ratio category or provide data to enable their calculation. Two researchers (CC, DZ) filtered the articles independently. From 2044 articles retrieved, three were considered eligible for inclusion in the meta-analysis. 10, 14, 15 Statistical analysis Data are presented as median with interquartile range (IQR) in the case of continuous variables with a skewed distribution or as the number (percentage) in the case of categorical variables. Participants were classified by TG/HDL-C ratio quartiles. Linear regression was used for continuous variables and logistic regression was used for categorical variables to test the linear trend.
Cox proportional hazards regression was used to estimate the risk of incident T2DM by calculating the HR and 95% CIs adjusted for age, sex, education level, physical activity, smoking, alcohol use, BMI, SBP, DBP, FPG, TC, and family history of T2DM at baseline. A sensitivity analysis was also performed to verify the robustness of our results by excluding specific individuals, such as those with impaired fasting glucose (IFG), hypertension, or a family history of diabetes at baseline. In addition, we fitted the restricted cubic spline to assess the dose-response relationship between the TG/HDL-C ratio and the risk of T2DM for males and females.
In the meta-analysis, the study-specific OR (per 1-unit increment in TG/HDL-C ratio) was calculated by a two-stage fixed-effects dose-response model, and the pooled OR was estimated by the DerSimonian and Laird random-effects model. 25 We also estimated the dose-response relationship between the TG/HDL-C ratio and the risk of onset T2DM to verify our conclusions in the cohort study. Finally, sources of heterogeneity were identified by excluding one study at a time, and publication bias was tested using Egger's test. 26 Statistical analyses were performed using SAS v.9.4 (SAS Institute, Cary, NC, USA) and STATA v12.0 (STATA Corp., College Station, TX, USA). Statistical significance was set at two-sided P < 0.05.
Results
Prospective cohort analysis
Among 10 741 participants (6568 females) included in the present study, 618 new cases of T2DM (370 females) were diagnosed during a median follow-up of 6 years. The cumulative incidence of T2DM was 9.68 per 1000 person-years overall. Compared with the first quartile (Q1) of the TG/HDL-C ratio, higher quartiles were associated with older age, female sex, smoking, drinking alcohol, and hypertension (P trend < 0.05 for all; Table 1 ). Moreover, height, weight, WC, BMI, SBP, DBP, FPG, and TC and TG levels increased and HDL-C levels decreased with increasing quartiles of the TG/HDL-C ratio (P trend < 0.05 for all).
The incidence of T2DM increased with increasing quartiles of the TG/HDL-C ratio (5.01, 6.87, 9.72, and 17.15 per 1000 person-years with Q1, Q2, Q3, and Q4, respectively; Table 2 ). After adjusting for potential confounding factors, people with in Q4 had twice the risk of T2DM incidence than those in Q1 (adjusted [a] HR 2.11, 95% CI 1.55-2.86). On sex-specific subgroup analysis, the risk of T2DM incidence was increased by 19% (95% CI 1.04-1.37) for males and by 27% (95% CI 1.16-1.39) for females with each 1-unit increment in the TG/HDL-C ratio. In different BMI subgroups, people with normal weight showed a stronger association between TG/HDL-C ratio and incident T2DM than overweight/obese individuals (aHR 1.34, 95% CI 1.13-1.58 for normal weight; aHR 1.29, 95% CI 1.15-1.44 for overweight; and aHR 1.19, 95% CI 1.04-1.36 for obesity). In addition, the TG/HDL-C ratio remained significantly associated with T2DM risk on sensitivity analysis after excluding individuals with IFG (aHR 1.26, 95% CI 1.13-1.39), hypertension (aHR 1.25, 95% CI 1.13-1.38), or a family history of diabetes at baseline (aHR 1.26, 95% CI 1.17-1.37). Figure 1 shows the non-linear relationship between the TG/HDL-C ratio and the risk of T2DM overall (P linear < 0.01). The curve shows that the risk of T2DM continued to increase with increasing TG/HDL-C ratio for females (P linear < 0.01), but a similar trend was observed for males only with a TG/HDL-C ratio < 2.5 (P linear < 0.01).
Meta-analysis of prospective studies
Information regarding the three published studies included in the meta-analysis and the present study is summarized in Table 3 . There were 20 302 people without diabetes and 2588 T2DM patients with diabetes across all four studies. The pooled OR per 1-unit increment in the TG/HDL-C ratio was 1.28 (95% CI 1.20-1.36; I 2 = 60.2%; P heterogeneity = 0.020; Fig. 2 ). Figure 3 shows the linear dose-response relationship between the TG/HDL-C ratio and T2DM risk overall (P linear = 0.326), and for males and females separately (P linear = 0.136 and 0.699, respectively), with the unfavorable association stronger in females than males.
None of the individual studies changed the summary risk substantially on sensitivity analysis removing one study at a time. We did not find a publication bias among the studies (P > 0.05, Egger's test).
Discussion
The present cohort study found that the TG/HDL-C ratio was independently and positively associated with the risk of T2DM incidence, especially for females. In addition, there was an increasing dose-response relationship between the TG/HDL-C ratio and T2DM incidence. Furthermore, these findings are consistent with the results of the meta-analysis of the present study and three published prospective studies. The present study strongly supports TG/HDL-C ratio as a risk factor for T2DM and suggests that the finding may be consistent worldwide.
Some previous prospective studies suggested that a high TG/HDL-C ratio increased the risk of incident T2DM, such as in Koreans, 15 Americans, 14, 27 and Iranians. 28 In Chinese people, only one communitybased cohort study including 687 adults with a 15-year Table 1 Demographic characteristics of participants without diabetes at baseline but type 2 diabetes mellitus at follow-up according to the triglycerides: high-density lipoprotein cholesterol ratio Quartiles (TG/HDL-C ratio) follow-up demonstrated that an increased TG/HDL-C ratio enhanced the risk of T2DM (OR 1.341; P = 0.010). 13 Consistent with those findings, we observed an increasing trend of T2DM risk with increasing TG/HDL-C ratio after adjusting for potential confounders in rural Chinese adults. Similarly, a cross-sectional study based on a community population in China suggested an increase in T2DM risk of 41% with a 1-quartile increment in the TG/HDL-C ratio. 11 However, only the present study analyzed the doseresponse relationship between the TG/HDL-C ratio and T2DM risk, finding an increasing curve in the overall population. Therefore, the evidence from the present study suggests that the TG/HDL-C ratio can be an important predictor of T2DM.
The TG/HDL-C ratio is closely related to IR and may be a proxy for IR to identify individuals at high risk of diabetes. 12, 29, 30 Many other surrogate markers of Unless indicated otherwise, data are given as hazard ratios (HRs) with 95% confidence intervals (CIs) in parentheses. The units for triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) were mg/dL. 2-h PG, plasma glucose 2-h after a glucose challenge; BMI, body mass index; BP, blood pressure; F, female; FPG, fasting plasma glucose; M, male; Q, quartile; T, tertile; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; WC, waist circumference.
IR have been used to predict incident T2DM, such as lipoprotein particle concentrations and size, glucose, and insulin levels. However, recent studies suggest that the TG/HDL-C ratio may be a better predictor of IR and cardiometabolic risk than single indicators, because a high TG and low HDL-C levels are two key metabolic abnormalities. 30, 31 In addition, people with a high TG/HDL-C ratio tend to have metabolic disturbances with higher BMI and higher FPG, TG, LDL-C, and very low-density lipoprotein cholesterol (VLDL-C) levels and lower HDL-C levels. 32 This evidence supports our contention that the TG/HDL-C ratio may be a good indicator for predicting T2DM.
The mechanisms by which the TG/HDL-C ratio causes T2DM are complex and unclear. Some studies found that high TG levels increase circulating free fatty acid levels, which further accelerates the increases in TG levels and reduces plasma HDL-C levels, related to IR, thus contributing to the progression of T2DM. 33, 34 Excessive TG and/or low HDL-C levels may affect the function of β-cells via inflammation and lipotoxicity regulation, further affecting insulin signaling and secretion. 35 In addition, low HDL-C levels could mediate glucose directly, thereby resulting in T2DM. 36 The sex-specific relationship between the TG/HDL-C ratio and T2DM incidence is well known. 10, 11, 15, 16 The Figure 3 Restricted cubic splines of the dose-response relationship between the triglycerides: high-density lipoprotein cholesterol (TG/HDL-C) ratio and type 2 diabetes mellitus (T2DM) on meta-analysis overall (a) and in males (b) and females (c) separately. The fitted values of odds ratios are showed by solid lines, and the corresponding 95% confidence interval are indicated by the dashed lines.
Figure 2
Forest plot of study-specific odds ratios (OR) for type 2 diabetes mellitus per 1-unit increment in the triglycerides: high-density lipoprotein cholesterol (TG/HDL-C) ratio. Diamonds indicate pooled odds ratios. BP, blood pressure; CI, confidence interval. present study found a slightly stronger association of T2DM with increasing TG/HDL-C ratios for females than males. Dose-response analysis showed differentshaped curves for the TG/HDL-C ratio versus T2DM risk between males and females. Similarly, a nested case-control study in a Singapore Chinese population including 571 people with diabetes and 571 controls found that females had a higher T2DM risk with increasing TG/HDL-C ratio. 10 In addition, similar findings have been reported in Chinese, 11 Korean, 15 and Iranian 16 populations. The possible mechanism underlying these observations is the difference in sex chromosomes, because reducing estrogen concentrations would promote disordered glycometabolism and lipid metabolism. 37 These studies imply that we should consider sex differences in preventing diabetes.
The results also stress that people with normal weight are not necessarily healthy. We found the strongest relationship between the TG/HDL-C ratio and T2DM incidence in people with normal weight. Similarly, a prospective nested case-control study found that an elevated TG/HDL-C ratio had a greater effect on risk of T2DM in Singapore Chinese individuals with BMI <23 compared with those with a BMI ≥23 kg/m 2 .
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Although how obesity affects dyslipidemia in diabetes is unclear, one hypothesis is an interaction between obesity and dyslipidemia. The present study suggests that obesity modifies the association between the TG/HDL-C ratio and T2DM risk. In normal-weight individuals, T2DM risk may be attributable more to dyslipidemia, 10 whereas in obese people T2DM risk can be modulated by better care interventions and other unrecognized pathological loads, such as chronic inflammation. 38 Therefore, although the TG/HDL-C ratio independently augmented the risk of diabetes incidence regardless of BMI, personalized prevention strategies based on different obesity exposures could be developed. Although previous studies concluded a significant association between the TG/HDL-C ratio and T2DM, we are the first to perform a sensitivity analysis, which gave robust results. The findings of the study performed on a Korean population without hypertension 15 are consistent with those of the present study. In addition, a cross-sectional study including 11 956 Chinese people with H-type hypertension found that, compared with the lowest quartile of the TG/HDL-C ratio, the risk of diabetes increased approximately twofold for those in the highest quartile. 39 The effects of lipids on diabetes may not be affected by hypertension. After excluding individuals with a family history of T2DM, the results in the present study remained the same. However, one cohort study of 1771 Iranian adults with a family history of T2DM found no association between the TG/HDL-C ratio and T2DM incidence (HR 0.90, 95% CI 0.74-1.09). 40 The difference is probably due to the strong association between a family history of T2DM and T2DM incidence, which may mask the substantial relationship between the TG/HDL-C ratio and T2DM incidence. Thus, more prospective studies with large samples are needed to confirm our conclusions.
Several limitations and strengths should be noted when interpreting the findings of the present study. The rural population is confined to the center of China and all participants were Han Chinese, which is not a good representative sample of Chinese people; in addition, the conclusions are restricted to Chinese people. Furthermore, T2DM was defined as FPG ≥7.0 mmol/L and/or the use of insulin or oral hypoglycemic medication and/or a self-reported history of T2DM, rather than being based on a 2-h oral glucose tolerance test or measurement of HbA1c, which may underestimate the incidence of T2DM. Finally, although a healthy diet could have beneficial effects on lipid homeostasis and glucose metabolism, 38 we did not assess dietary data in the present study. Further studies are needed to determine how diet affects the relationship between TG/HDL-C and T2DM risk.
However, the present study has several strengths. First, the present study is by far the largest prospective cohort study of the association between TG/HDL-C ratio and T2DM incidence with the ability to follow-up individuals over time. The data were robust and the conclusions convincing. Second, it was a well-designed study with low rate of loss to follow-up, and the use of uniformly trained investigators and standardized procedures, including a standard questionnaire, physical examination, and biochemical tests. In addition, we performed a meta-analysis with the findings of the present study and those of three prospective studies to verify our results.
In summary, the findings demonstrate that an increased TG/HDL-C ratio elevates the risk of T2DM incidence in rural Chinese adults, especially females, and the dose-response relationship suggests that the TG/HDL-C ratio may be a useful predictor of future T2DM. Meanwhile, treating dyslipidemia may be one way to prevent diabetes. Further studies are needed to verify the findings in other populations.
